Ulcerative Colitis Executive Market Summary

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Oncology Research Digest H1 2014

Oncology Research Digest H1 2014

  • $ 350
  • Industry report
  • by TBRC Business Research
  • August 2014
  • 19 pages

The Oncology Research Digest is a digest of all the most important research in the oncology market each quarter, and available as an annual subscription. It covers areas such as biosimilars, novel immunotherapies, non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer, ovarian cance ...

Industries: Pathology | Countries: China, World, United States, India, Asia

Cardiovascular Diseases Therapeutics Market in Asia Pacific to 2019 - Promising Pipeline Drugs to Offset Revenue Decline from Generic Erosion and Off-Label Use

Cardiovascular Diseases Therapeutics Market in Asia Pacific to 2019 - Promising Pipeline Drugs to Offset Revenue Decline from Generic Erosion and Off-Label Use

  • $ 3 500
  • Industry report
  • by GBI Research
  • November 2013
  • 93 pages

Cardiovascular Diseases Therapeutics Market in Asia Pacific to 2019 - Promising Pipeline Drugs to Offset Revenue Decline from Generic Erosion and Off-Label Use Summary GBI Research has released its pharmaceutical research, "Cardiovascular Diseases Therapeutics Market in Asia Pacific to 2019 - Promising ...

Industries: Pathology | Countries: World, Australia, India, Japan, China, Asia

PharmaPoint: Atopic Dermatitis - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Atopic Dermatitis - Global Drug Forecast and Market Analysis to 2022

  • $ 9 995
  • Industry report
  • by Global Data
  • November 2013
  • 287 pages

PharmaPoint: Atopic Dermatitis - Global Drug Forecast and Market Analysis to 2022 Summary Although the past decade has seen the atopic dermatitis market remain relatively unchanged and a saturated, highly genericized arena, the coming decade could see the launch of the first biologic, which will set ...

Industries: Pathology | Countries: World, India, China, Japan, Spain, Italy, France, Germany, United States, United Kingdom, Europe, Asia

Therapy Class Overview : Hepatitis C Virus Infection

Therapy Class Overview : Hepatitis C Virus Infection

  • $ 1 000
  • Industry report
  • by MP Advisors
  • October 2013
  • 33 pages

Freedom from injecting Interferon (IFN), treating major HCV genotypes WW and betting on vaccines could bring a sea of change in the treatment of HCV infection in the future. This year the first IFN-free drug options for HCV Genotype 2/3- Gilead's Sofosbuvir/RBV (GS-7977, PDUFA Dec. 8, 2013) is expected ...

Industries: Pathology | Countries: Asia, World, Australia, Saudi Arabia, Vietnam, Taiwan, Syrian Arab Republic, Pakistan, India, China, Egypt

Solid Tumors Market in Asia Pacific to 2019 - New Drug Approvals and Anticipated Product Launches to Trigger a Shift in Treatment Paradigm to Targeted Therapies

Solid Tumors Market in Asia Pacific to 2019 - New Drug Approvals and Anticipated Product Launches to Trigger a Shift in Treatment Paradigm to Targeted Therapies

  • $ 3 500
  • Industry report
  • by GBI Research
  • September 2013
  • 111 pages

Solid Tumors Market in Asia Pacific to 2019 - New Drug Approvals and Anticipated Product Launches to Trigger a Shift in Treatment Paradigm to Targeted Therapies Summary GBI Research, the leading business intelligence provider, has released its latest research, “Solid Tumors Market in Asia Pacific to ...

Industries: Pathology | Countries: World, Australia, China, Japan, India, Asia

Alimta (Non-Small Cell Lung Cancer) - Forecast and Market Analysis to 2022

Alimta (Non-Small Cell Lung Cancer) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • by Global Data
  • June 2013
  • 54 pages

Alimta (Non-Small Cell Lung Cancer) - Forecast and Market Analysis to 2022 Summary Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered around chemotherapy. However, the launch of targeted ...

Industries: Pathology | Countries: Japan, Spain, Italy, France, Germany, India, China, World, United States, Europe, United Kingdom, Asia

Liver Cancer (Hepatocellular Carcinoma): Disease and Pipeline Analysis

Liver Cancer (Hepatocellular Carcinoma): Disease and Pipeline Analysis

  • $ 2 960
  • Industry report
  • by Industry Standard Research
  • May 2013
  • 60 pages

This report offers a unique therapeutic assessment and in-depth market and pipeline analysis, providing a view of the hepatocellular carcinoma (liver cancer) market not available elsewhere. The purpose of this report is to give an extensive overview of the current and future liver cancer market, the ...

Industries: Pathology | Countries: South Korea, World, United States, United Kingdom, Brazil, Spain, Russian Federation, Italy, France, Germany, Japan, India, China, Europe, Asia

EpiCast Report: Psoriasis - Epidemiology Forecast to 2022

EpiCast Report: Psoriasis - Epidemiology Forecast to 2022

  • $ 3 995
  • Industry report
  • by Global Data
  • March 2013
  • 40 pages

EpiCast Report: Psoriasis - Epidemiology Forecast to 2022 Summary Psoriasis is an immune-mediated chronic disorder of the skin characterized by redness and irritation. It affects people of both sexes and of all ages and races/ethnicities. The global prevalence of psoriasis varies geographically, with ...

Industries: Pathology | Countries: India, Japan, China, World, United States, Asia, Europe, Spain, Italy, France, Germany

EpiCast Report: Crohn's Disease Epidemiology Forecast to 2022

EpiCast Report: Crohn's Disease Epidemiology Forecast to 2022

  • $ 3 995
  • Industry report
  • by Global Data
  • January 2013
  • 56 pages

EpiCast Report: Crohn's Disease Epidemiology Forecast to 2022 Summary Crohn's disease is a form of inflammatory bowel disease (IBD) characterized by recurrent inflammation of all or part of the gastrointestinal tract (CDC, 2011). Globally, the incidence rates for Crohn's disease vary between 0.3 cases ...

Industries: Pathology | Countries: United States, Canada, Japan, India, China, Spain, Italy, France, Germany, World, United Kingdom, Europe, Asia, North America

Global Markets for Diabetes Therapeutics and Diagnostics -- Focus on Asia

Global Markets for Diabetes Therapeutics and Diagnostics -- Focus on Asia

  • $ 5 370
  • Industry report
  • by BCC Research
  • January 2013
  • 135 pages

INTRODUCTION STUDY GOALS AND OBJECTIVES The aim of this report is to provide detailed market, technology, and industry analyses to help readers quantify and qualify the market for drugs used in the treatment of diabetes and for devices and instruments used in the diagnosis and monitoring of diabetes. ...

Industries: Pathology | Countries: World, India, Japan, Asia, China

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.